Parametric Portfolio Associates’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Parametric Portfolio Associates’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22	Closed	-$136K	–	3597
2021 Q1	$136K	Sell	22 -1	-4%	-$7.25K	﹤0.01%	3940
2020 Q4	$133K	Sell	23 -5	-18%	-$31.4K	﹤0.01%	3856
2020 Q3	$167K	Buy	28 +11	+65%	+$64.2K	﹤0.01%	3711
2020 Q2	$106K	Sell	17 -5	-23%	-$33.9K	﹤0.01%	3776
2020 Q1	$208K	Buy	22 +13	+144%	+$204K	﹤0.01%	3538
2019 Q4	$149K	Buy	9 +1	+13%	+$16.7K	﹤0.01%	3800
2019 Q3	$134K	Sell	8 -11	-58%	-$178K	﹤0.01%	3782
2019 Q2	$401K	Buy	19 +8	+73%	+$198K	﹤0.01%	3463
2019 Q1	$303K	Buy	11 +6	+120%	+$144K	﹤0.01%	3545
2018 Q4	$67K	Buy	+5	New	+$112K	﹤0.01%	3824

Other funds holding YARW

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Parametric Portfolio Associates's YARW Position: Q2 2021 in Review

Parametric Portfolio Associates sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q2 2021, closing a stake of 22 shares — an estimated $136K sold.

Parametric Portfolio Associates first reported a position in YARW in Q4 2018 and held it in 10 quarters. The position peaked at $401K in Q2 2019. 63 funds tracked by Wall St. Rank hold YARW as of Q2 2021.

Parametric Portfolio Associates reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Parametric Portfolio Associates sold 22 Yarrow Bioscience, Inc. Common Stock shares in Q2 2021, an estimated $136K.
Parametric Portfolio Associates first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2018 and held it in 10 quarters.
Parametric Portfolio Associates's Yarrow Bioscience, Inc. Common Stock position peaked at $401K in Q2 2019.
63 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q2 2021.

Based on Parametric Portfolio Associates's 13F filing for Q2 2021, filed 13 Aug 2021.